Israeli researchers at the Technion have identified new biological markers that may enable the early diagnosis of preeclampsia, a potentially life-threatening pregnancy disorder. By studying placenta cells from women with preeclampsia, they observed alterations in gene expression leading to inflammation and related issues. These markers could be utilized to develop a blood test or other diagnostic tool for detecting preeclampsia before symptoms manifest. Early detection would enable timely intervention, increasing the likelihood of a healthy outcome for both the mother and baby. Preeclampsia is a serious pregnancy condition marked by high blood pressure, protein in the urine, and severe swelling, which, if left untreated, can lead to severe complications and, in some cases, fatalities for both parties involved.
Source – CGTN